Divergent signaling requirements of dSARM in injury-induced degeneration and developmental glial phagocytosis
Authors: Kelsey A Herrmann, Yizhou Liu, Arnau Llobet-Rosell, Colleen N McLaughlin, Lukas J Neukomm, Jaeda C Coutinho-Budd, Heather T Broihier
Journal: PLOS Genetics
Accepted: 2022-05-13T00:00:00Z


Elucidating signal transduction mechanisms of innate immune pathways is essential to defining how they elicit distinct cellular responses. Toll-like receptors (TLR) signal through their cytoplasmic TIR domains which bind other TIR domain-containing adaptors. dSARM/SARM1 is one such TIR domain adaptor best known for its role as the central axon degeneration trigger after injury. In degeneration, SARM1’s domains have been assigned unique functions: the ARM domain is auto-inhibitory, SAM-SAM domain interactions mediate multimerization, and the TIR domain has intrinsic NAD+ hydrolase activity that precipitates axonal demise. Whether and how these distinct functions contribute to TLR signaling is unknown. Here we show divergent signaling requirements for dSARM in injury-induced axon degeneration and TLR-mediated developmental glial phagocytosis through analysis of new knock-in domain and point mutations. We demonstrate intragenic complementation between reciprocal pairs of domain mutants during development, providing evidence for separability of dSARM functional domains in TLR signaling. Surprisingly, dSARM’s NAD+ hydrolase activity is strictly required for both degenerative and developmental signaling, demonstrating that TLR signal transduction requires dSARM’s enzymatic activity. In contrast, while SAM domain-mediated dSARM multimerization is important for axon degeneration, it is dispensable for TLR signaling. Finally, dSARM functions in a linear genetic pathway with the MAP3K Ask1 during development but not in degenerating axons. Thus, we propose that dSARM exists in distinct signaling states in developmental and pathological contexts.
Author summary: Following injury, severed axons are actively destroyed by a protein called SARM1, or dSARM in Drosophila. It was recently shown that dSARM/SARM1 accomplishes this feat by degrading the key coenzyme NAD+, leading to energetic collapse in the axon. This was surprising since dSARM/SARM1 is a TIR-domain containing protein, and as such, was thought to act exclusively as an adaptor in Toll receptor-mediated pathways. We recently uncovered a developmental role for dSARM in glia where it promotes engulfment of dying neurons. To understand the relationship between this function for dSARM and its better-known function in axon degeneration, we set out to (1) compare the enzymatic requirement of dSARM in both settings, and (2) determine if signaling mechanisms are the same. To address these questions, we used CRISPR to generate new dSARM knock-in alleles. We find that the NAD+ hydrolase activity of dSARM is absolutely required for both its axon degeneration function and its signaling function. Pointing to differences in dSARM-mediated pathways in the two contexts, we provide evidence that Ask1 kinase is required for dSARM signaling in glia but not for axon degeneration. Thus, we propose that the NAD+ hydrolase activity of dSARM leads to Ask1 activation and subsequent signal transduction.